Prospective Observational Study to Investigate the Added Value of the Health Related Quality of Life and Patient Reported Symptoms in the Identification of the Recommended Phase II Dose in Phase I Trials of Molecularly Targeted Therapies.
Clinical trial NCT02857699 · UNKNOWN
Trial details
- NCT number
- NCT02857699
- Sponsor
- Institut Curie
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2014-04-01
- Primary completion
- 2017-06-01
- Enrollment
- 250
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.